Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation

Neuromuscular Disorders

Volumn 11, Issue 4, 2001, Pages 341-349

  Espinos, E ^a   Liu, J H ^a   Bader, C R ^a   Bernheim, L ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Electroporation; Gene therapy; Human primary myoblasts; Ionic currents; Myoblast fusion

Indexed keywords

DNA;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTROPORATION; FLUORESCENCE; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; ION CURRENT; MYOBLAST; PLASMID; PRIORITY JOURNAL;

CELL FUSION; CELLS, CULTURED; DNA; ELECTRIC CONDUCTIVITY; ELECTROPORATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; ION CHANNELS; MUSCLE, SKELETAL; STEM CELLS; TRANSFECTION; VIRUSES;

EID: 0035030907     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(00)00204-2     Document Type: Article

References (55)

1. Morgan JE. Cell and gene therapy in Duchenne muscular dystrophy. Hum Gene Ther 1994;5:165-173.
2. Partridge T. Skeletal muscle as a target for gene therapy (editorial). Gene Ther 1994;1:77-79.
3. Partridge TA, Morgan JE, Coulton GR, Huffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
4. Dalle B, Payen E, Regulier E, et al. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts. Gene Ther 1999;6:157-161.
5. Gros L, Riu E, Montoliu L, et al. Insulin production by engineered muscle cells. Hum Gene Ther 1999;10:1207-1217.
6. Wang JM, Zheng H, Blaivas M, Kurachi K. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels. Blood 1997;90:1075-1082.
7. Yao SN, Smith KJ, Kurachi K. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther 1994;1:99-107.
8. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999;144:1113-1122.
9. Qu Z, Balkir L, Van Deutekom JC, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-1267.
10. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997;3:970-977.
11. Kakulas BA. Problems and potential for gene therapy in Duchenne muscular dystrophy. Neuromusc Disord 1997;7:319-324.
12. Karpati G, Ajdukovic D, Arnold D, et al. Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993;34:8-17.
13. Miller RG, Sharma KR, Pavlath GK, et al. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997;20:469-478.
14. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993;2:99-112.
15. Merly F, Huard C, Asselin I, Robbins PD, Tremblay JP. Anti-inflammatory effect of transforming growth factor-betal in myoblast transplantation. Transplantation 1998;65:793-799.
16. Kato K, Shimozato O, Hoshi K, et al. Local production of the p40 subunit of interleukin 12 suppresses T- helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 1996;93:9085-9089.
17. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 1991;2:5-14.
18. Yang NS, Burkholder J, Roberts B, Martineil B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990;87:9568-9572.
19. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7:2745-2752.
20. Dodds E, Dunckley MG, Naujoks K, Michaelis U, Dickson G. Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Ther 1998;5:542-551.
21. Trivedi RA, Dickson G. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J Neurochem 1995;64:2230-2238.
22. Vitiello L, Chonn A, Wasserman JD, Duff C, Worten RG. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Ther 1996;3:396-404.
23. Vitiello L, Bockhold K, Joshi PB, Worten RG. Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE liposomes. Gene Ther 1998;5:1306-1313.
24. Clapper DL, Lee HC. Inositol trisphosphate induces calcium release from non-mitochondrial stores in sea urchin egg homogenates. J Biol Chem 1985;260:13947-13954.
25. Traas JA, Doonan JH, Rawlins DJ, et al. An actin network is present in the cytoplasm throughout the cell cycle of carrot cells and associates with the dividing nucleus. J Cell Biol 1987;105:387-395.
26. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982;1:841-845.
27. Wong TK, Neumann E. Electric field mediated gene transfer. Biochem Biophys Res Commun 1982;107:584-587.
28. Andreason GL, Evans GA. Optimization of electroporation for transfection of mammalian cell lines. Anal Biochem 1989;180:269-275.
29. Chang DC, Gao PQ, Maxwell BL. High efficiency gene transfection by electroporation using a radio-frequency electric field. Biochim Biophys Acta 1991;1092:153-160.
30. Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 1987;15:1311-1326.
31. Knutson JC, Yee D. Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem 1987;164:44-52.
32. Tekle E, Astumian RD, Chock PB. Electroporation by using bipolar oscillating electric field: an improved method for DNA transfection of NIH 3T3 cells. Proc Natl Acad Sci USA 1991;88:4230-4234.
33. Wolf H, Rols MP, Boldt E, Neumann E, Teissie J. Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys J 1994;66:524-531.
34. Calvin NM, Hanawalt PC. High-efficiency transformation of bacterial cells by electroporation. J Bacteriol 1988;170:2796-2801.
35. Miller JF, Dower WJ, Tompkins LS. High-voltage electroporation of bacteria: genetic transformation of Campylobacter jejuni with plasmid DNA. Proc Natl Acad Sci USA 1988;85:856-860.
36. Xie TD, Sun L, Tsong TY. Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane pores. Biophys J 1990;58:13-19.
37. Meilhoc E, Masson JM, Teissie J. High efficiency transformation of intact yeast cells by electric field pulses [published erratum appears in Biotechnology (NY) 1990 Aug;8(8):768]. Biotechnology (NY) 1990;8:223-227.
38. Fromm ME, Taylor LP, Walbot V. Stable transformation of maize after gene transfer by electroporation. Nature 1986;319:791-793.
39. Baroffio A, Hamann M, Bernheim L, et al. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 1996;60:47-57.
40. Baroffio A, Aubry JP, Kaelin A, et al. Purification of human muscle satellite cells by flow cytometry. Muscle Nerve 1993;16:498-505.
41. Krause RM, Hamann M, Bader CR, et al. Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts. J Physiol (Lond) 1995;489:779-790.
42. Occhiodoro T, Bernheim L, Liu JH, et al. Cloning of a human ether-ago-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 1998;434:177-182.
43. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981;391:85-100.
44. + current. Ih-eag, contributes to the hyperpolarization of human fusion-competent myoblasts. J Physiol (Lond) 1998;512:317-323.
45. + current and of hyperpolarization in human myoblast fusion. J Physiol (Lond) 1998;510:467-476.
46. Widmer H, Hamann M, Baroffio A, Bijlenga P, Bader CR. Expression of a voltage-dependent potassium current precedes fusion of human muscle satellite cells (myoblasts). J Cell Physiol 1995;162:52-63.
47. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-394.
48. Fisher KJ, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
49. Schofield JP, Caskey CT. Non-viral approaches to gene therapy. Br Med Bull 1995;51:56-71.
50. Treco DA, Selden RF. Non-viral gene therapy. Mol Med Today 1995;1:314-321.
51. Kubiniec RT, Liang H, Hui SW. Effects of pulse length and pulse strength on transfection by electroporation. Biotechniques 1990;8:16-20.
52. Li LH, Ross P, Hui SW. Improving electrotransfection efficiency by post-pulse centrifugation. Gene Ther 1999;6:364-372.
53. Chang DC. Cell poration and cell fusion using an oscillating electric field. Biophys J 1989;56:641-652.
54. Andreason GL, Evans GA. Introduction and expression of DNA molecules in eukaryotic cells by electroporation [published erratum appears in Biotechniques 1988 Oct;6(9):853. Biotechniques 1988;6:650-660.
55. Bernheim L, Liu JH, Hamann M, et al. Contribution of a non-inactivating potassium current to the resting membrane potential of fusion-competent human myoblasts. J Physiol (Lond) 1996;493:129-141.